Amneal Pharmaceuticals, Inc. AMRX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $78M+217% | $49.57M+339% | $18.13M+54.2% | $35.61M+112% | $24.62M+130% | ||
| $8.82M+21.5% | $8.2M+13.8% | $8.22M+15.6% | $8.27M+23.1% | $7.26M+8.0% | ||
| -$26.74M-461% | $130.32M+10.4% | $118.45M-16.5% | $83.82M+111% | $7.41M+268% | ||
| $8.18M-37.9% | $21.77M+43.7% | $12.3M-27.4% | $22.83M+115% | $13.16M+43.1% | ||
| -$21.71M-22.0% | -$45.45M-183% | -$22.46M-8.5% | -$26.55M-311% | -$17.8M+9.9% | ||
| $134.67M— | $2.48B+5,260% | $0— | $218M— | $0-100% | ||
| -$59.06M-50.8% | -$10.12M+83.5% | —— | -$41.69M-18.8% | -$39.17M-69.1% | ||
| -$108.53M-117% | $74.53M+86.0% | $154.74M+439% | $15.28M+866% | -$50.03M-5.3% | ||
| -$34.92M-507% | $108.54M+5.5% | $106.15M-15.0% | $60.99M+110% | -$5.75M+57.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Amneal Pharmaceuticals, Inc. generate?
- Amneal Pharmaceuticals, Inc. (AMRX) generated $305.8M in operating cash flow over the trailing twelve months.
- What is Amneal Pharmaceuticals, Inc.'s free cash flow?
- After $65.1M of capital expenditures, Amneal Pharmaceuticals, Inc.'s free cash flow was $240.8M over the trailing twelve months, down 4.1% year over year.
- Where does Amneal Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Amneal Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
